Skip to main content

Advertisement

Table 1 Participant demographics

From: Muscle synergies demonstrate only minimal changes after treatment in cerebral palsy

Treatment N GMFCS Age Gender Height Mass
   I/II/III y + mo F:M meters kg
BTA 52 18/19/15 6 + 10 (2 + 11) 19:33 1.15 (0.16) 21.3 (8.7)
SDR 38 11/23/4 9 + 4 (2 + 0) 20:18 1.33 (0.10) 29.7 (6.2)
SEMLS 57 20/17/20 12 + 2 (3 + 1) 23:34 1.45 (0.16) 39.3 (14.8)
TD 31 9 + 3 (2 + 9) 17:14 1.38 (0.17) 33.8 (13.3)
  1. NOTE. Values are average (1 SD) or as otherwise indicated
  2. N Number of Participants, GMFCS Gross Motor Function Classification System, y + mo Years + Months, F Female, M Male, BTA Botulinum Toxin Type-A Injection,
  3. SDR Selective Dorsal Rhizotomy, SEMLS Single Event Multi-Level Orthopaedic Surgery, TD Typically-Developing Children